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Abstract The Saccharomyces cerevisiae proteins Spt4p, Spt5p 
and Spt6p are involved in transcriptional repression by modulat-
ing the structure of chromatin. From HeLa cells we have purified 
a human homologue of Spt5p, SuptShp, and show here that the 
protein is reversibly phosphorylated in mitosis. The cloned cDNA 
predicts a protein of 1087 residues with 31% identity to yeast 
Spt5p. It includes an acidic N-terminus, a putative nuclear 
localization signal and a C-terminal region containing two 
different repeated motifs. One of them, with the consensus 
sequence P-T/S-P-S-P-Q/A-S/G-Y, is similar to the C-terminal 
domain in the largest subunit of RNA polymerase II. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The structure of chromatin is modified by proteins that 
interact with histones and promote either a relaxed state of 
chromatin, suitable for transcription, or a more compact and 
transcriptionally inactive state [1,2]. Factors, like the large Snf/ 
Swi complex, facilitate the initiation of transcription by inter-
action with nucleosomes and the R N A polymerase II complex 
[3].In Saccharomyces cerevisiae a deficiency in the activating 
Swi/Snf complex is suppressed by mutat ions in the SPT4, 
SPT5 and SPT6 genes [4—6], indicating that the wild-type 
proteins are involved in transcriptional repression. Mutat ions 
in these genes were also shown to alter transcription of a 
subset of histone genes in S. cerevisiae [7]. Since double mu-
tant combinations of spt4, spt5 and spt6 are generally lethal in 
haploid strains, the corresponding wild-type proteins may 
form a heterotrimeric complex. The co-immunoprecipitation 
of Spt5p and Spt6p also indicates a physical interaction of 
these proteins [8]. The chromatin remodelling-mechanism of 
the postulated Spt protein complex may in part be explained 
the finding that Spt6p interacts directly with the globular do-
main of histone H3 and that it functions as a nucleosome 
assembly factor which assists histones in binding to D N A [9]. 
The SPT4 gene encodes a small protein of 102 amino acid 
residues, whereas Spt5p (1063 residues) and Spt6p (1726 res-
idues) are considerably larger proteins with highly acidic N -
terminal regions. Null mutants of SPT4 are viable [10], while 
the deletion of SPT5 or SPT6 has a lethal effect, indicating 
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that a main function of the complex is carried out by the 
SPT5 and SPT6 gene products. Recently, SUPT4H and 
SUPT6H, the human homologues of the SPT4 and SPT6 
genes, have been cloned [11-13]. We report here the purifica-
tion of Supt5hp, a human homologue of yeast Spt5p, its mi-
totic phosphorylation, and the cloning and sequencing of the 
SUPT5H cDNA. 
2. Materials and methods 
2.1. Generation of antibodies and purification of SuptShp 
HeLa cells were cultivated as described before [14]. For cell cycle 
studies, cells were synchronized in S-phase by a double thymidine 
block [15] and the subsequent arrest in mitosis was achieved by a 
nocodazole block [16]. Monoclonal antibody 8001 was one of a set 
raised against proteins from mitotic HeLa cell lysates. It was charac-
terized as IgMK and used to monitor the purification of Supt5hp. This 
was then used to generate polyclonal antibody AS40 by immunizing 
chicken and preparing antibodies from the eggs. 
Initially, monoclonal antibody 8001 was used to monitor Supt5hp 
isolation. In subsequent routine procedures the more sensitive anti-
body AS40 was used. Fractions containing Supt5hp were identified in 
immunoblots stained with either of the two antibodies, and the inten-
sity of the stain was determined densitometrically. All purification 
steps were performed at 4°C. Frozen HeLa cells (4X1010, 100 g wet 
weight) were thawed, resuspended in 200 ml of buffer A (20 mM bis-
Tris-propane-HCl (Sigma), pH 6.9, containing 20% glycerol, 1 mM 
dithiothreitol and protease inhibitors, swollen on ice for 30 min and 
homogenized by 35 strokes in a S-type Dounce homogenizer (Braun, 
Melsungen). Insoluble material was removed by centrifugation (30 
min at 70000Xg). The pellet was resuspended in 100 ml of buffer 
A containing 50 mM NaCl, and again centrifuged for 30 min at 
70 000Xg. The two supernatants were pooled, solid ammonium sul-
fate was added with continuous stirring up to 30% saturation. The 
suspension was further stirred for 1 h at 4°C. After spinning down 
precipitated protein (30 min at 70 000 X g), the pellet was dissolved in 
25 ml of buffer A containing 100 mM NaCl and applied to an 
DMAE-Fractogel 650 S column (1.2x10 cm, Merck) equilibrated 
with buffer A containing 100 mM NaCl. Bound protein was eluted 
by applying a linear gradient of 250 mM-1 M NaCl at a flow rate of 
1.2 ml/min. The fractions containing Supt5hp were diluted 10-fold in 
buffer B (50 mM Mes-NaOH, pH 6.9, containing 20% glycerol and 
1 mM dithiothreitol) and applied to an S03-Fractogel 650S column 
(0.5X5 cm, Merck) equilibrated with buffer B containing 140 mM 
NaCl. Bound protein was eluted by applying a linear gradient of 
140 mM-2 M NaCl at a flow rate of 0.4 ml/min. The fractions con-
taining Supt5hp were diluted 10-fold in buffer A containing 200 mM 
NaCl, and applied to a MonoQ column (0.5X5 cm, Pharmacia) equi-
librated with the same buffer. Bound protein was eluted by applying a 
linear gradient of 200^100 mM NaCl at a flow rate of 0.4 ml/min. 
After electrophoresis, SDS gels were stained with Coomassie blue 
R250 and scanned in a laser densitometer, with bovine serum albumin 
as standard. 
2.2. Amino acid sequences of peptides and cloning of SUPT5H 
Ten micrograms of the purified protein was cleaved in 0.1 M 
NH4HCO3 and 1 M urea with N-Asp protease for 2 h at 25°C. 
The reaction was stopped by addition of 15% (v/v) TFA. Another 
aliquot of 10 jig was cleaved in 75% formic acid with CNBr for 20 
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h at 25°C. The resulting peptides were separated by reversed phase 
HPLC (C18) in 0.1% TFA, 5-72% acetonitrile and sequenced with a 
gas-phase sequencer (Model 470A, Applied Biosystems). The Tblastn 
program (part of the HUSAR program package, DKFZ) was used to 
search the databases for nucleotide sequences corresponding to the 
peptide sequences obtained. 
Total RNA was obtained from logarithmically growing HeLa cells 
using the RNA-Clean kit (AGS, Heidelberg, Germany). Reverse tran-
scriptase-mediated PCR was performed on total RNA using the 
SuperScript reverse transcriptase (Life Technologies). Clone 322 was 
amplified by RT-PCR using as forward and reverse primers: 5'-gac c-
ga ccc ccc aag aaa ccc-3' and 5'-ggg ate ctt gac tec ctg gga-3', re-
spectively. PCR products were cloned directly into the pCRII vector 
(Invitrogen). 
HeLa and testis libraries were plated on E. coli Y1090- with ap-
proximately 5X 104 plaque-forming units per 150 mm plate, and were 
lifted on Hybond N + membranes (Amersham). Fifty nanograms of 
cDNA clones were labelled (DECAprimell kit, Ambion) with 50 uCi 
[oc-32P]dCTP and hybridized to the membranes. Positive clones were 
selected and DNA was eluted (35 mM Tris/HCl, pH 7.5, 10 mM 
MgSC-4, 0.1 M NaCl, 0.01% gelatin). Phage DNA was replated and 
further rounds of screening were performed. Phage DNA of single 
plaques was purified and cut with EcoRl in the presence of 10 mM 
spermidine. The inserts obtained were purified as before, eluted and 
cloned into the EcoKI sites of pCRII. DNA sequencing was per-
formed with an ALFexpress (Pharmacia) DNA sequencer and with 
an ABI sequencer Model 373A (Applied Biosystems). 
5'-RACE was performed on testis cDNA (Marathon-Ready kit, 
Clontech) with the primer: 5'-etc tag aat gtc etc tgc tec ate etc c-
ca ctg gtc ctc-3'. Twenty-six cycles were performed with 68°C for 
1 min, 72°C for 2 min and 92°C for 1 min. Two microliters of the 
50 ul reaction mixture were removed and used as a template for 
further reamplification under the same conditions. The PCR products 
were analyzed on agarose gels and cloned into pCRII vectors. EST 
clones from the IMAGE Consortium (LLNL) [17] were obtained from 
Research Genetics (Huntsville, AL). 
3. Results 
3.1. Purification of Supt5hp from HeLa cells 
In a study to identify proteins involved in cell cycle regula-
tion, we had generated a set of monoclonal antibodies raised 
against proteins from mitotic HeLa cells. One of them, anti-
body 8001, in immunofluorescence studies stained a nuclear 
epitope in interphase HeLa cells (data not shown) and de-
tected a protein with an apparent mass of approximately 155 
kDa in immunoblots (Fig. IB, lane 10). Using this antibody to 
monitor enrichment, the protein we later identified as Supt5hp 
was purified from lysates of logarithmically growing HeLa 
cells by fractionation as described in Section 2 and enriched 
32500-fold to apparent homogeneity (Fig. 1A and Table 1). In 
order to confirm the results obtained with monoclonal anti-
body 8001, the purified protein was used to raise polyclonal 
antibodies in a chicken. Antibody preparations collected from 
the eggs of this chicken were designated AS40. Both antibodies 
displayed an identical distribution pattern of a 155 kDa pro-
tein in the various protein fractions, both detected the purified 
Fig. 1. Purification of Supt5hp from HeLa cells. A: 12.5% SDS-
PAGE of protein fractions stained with Coomassie brilliant blue. B : 
10% SDS-PAGE: Total soluble HeLa protein, immunostained with 
monoclonal antibody 8001 (lane 10), or immunostained using the 
polyclonal antibody AS40 (lane 11), or pre-immune immunoglobulin 
(lane 12). 
155 kDa protein in immunoblots (Fig. 1A, lane 9), and both 
stained the nuclei of interphase HeLa cells. By comparative 
immunoblotting using AS40, we estimated the amount of the 
protein to be 20000 copies/HeLa cell; representing ~0.0025% 
of the total cellular protein (data not shown). 
3.2. Cloning of SUPT5H 
We cleaved aliquots of the antigenic protein by N-Asp pro-
tease and CNBr. The resulting fragments were separated by 
HPLC and 15 of them were sequenced. A data base search 
using the Tblastn program yielded one cDNA clone (T18964) 
which, in its translated open reading frame, contained the se-
quence of one of the peptide fragments (residues 131-152 in 
Fig. 2). Based on this sequence, primers were designed and 
used to amplify a fragment of 342 bp (clone 322) from HeLa 
cDNA. A A,gtl0 HeLa library was screened with this fragment 
yielding a clone with a 792 bp insert, designated clone 13. 
Furthermore, another peptide fragment (residues 796-810 in 
Fig. 2) was found in the translated sequences of a number of 
expressed sequence tags in the GenBank database (R59954, 
R73139, R14898 and T80145). Clone R14898 represents a se-
quence of 1517 bp including a poly(A) tail and a polyadenyla-
tion signal. With pooled DNA from clones 13 and R14898 a 
JigtlO testis library was screened, yielding two overlapping 
clones of 972 bp and 1430 bp, respectively. The sequence 
was extended by 5'-RACE for a further 320 bp. A new data-
base search with the complete sequence identified two addi-
tional EST clones (R18289 and W73325) of 2391 bp and 
3276 bp, respectively, which were sequenced and confirmed 
the sequence already established. The sequence data are corro-
borated by the microsequencing data of the Supt5hp peptides. 
Table 1 
Purification of Supt5h from HeLa cells 
Fraction 
Crude lysate 
Soluble protein 
30% Ammonium sulfate precipitate 
DMAE-Fractogel 
SCVFractogel 
MonoQ 
Total protein (mg) 
7920 
3872 
184 
4.2 
0.37 
0.06 
Supt5hp (|ig) 
200 
160 
150 
120 
94 
60 
Purification factor 
1.3 
26.7 
943 
8300 
32500 
Recovery (%) 
100 
80 
75 
60 
47 
30 
Crude lysate was obtained from 100 g of packed HeLa cells (4X 1010 cells). Supt5h was quantitated by the staining of gels with Coomassie blue and 
of immunoblots with AS40 antibodies to Supt5h. 
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3613 acctcctccccacagcttgcttttgttgtaccgtctttcaataaaaagaagctgtttggtctaaaaaaaaaaaaaaaaaaaaaaaa 
lit0 
ïlV 
1985 
614 
?ÏS5 
2510 
789 
II? 
Iff 
3185 
1014 
3512 
3612 
3698 
Fig. 2. cDNA and derived amino acid sequence of SUPT5H. The 5'- and 3'-UTRs are printed in lower case, the polyadenylation signal is 
highlighted in bold. Amino acid sequences confirmed by microsequencing of purified Supt5hp are underlined. Acidic residues of the N-terminal 
region are boxed, as is the putative NLS signal. The CTRl and CTR2 repeats are boxed and marked differently. 
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3.3. SUPT5H cDNA and predicted structure of the encoded 
protein 
The SUPT5H cDNA has a length of 3699 bp, with an open 
reading frame of 3261 bp, predicting a protein of 1087 amino 
acid residues (Fig. 2). The 3'-UTR of 270 bp contains a poly-
adenylation signal (AATAAA), preceding a poly(A) tail by 17 
bp. A 5'-UTR region of 143 bp precedes a start ATG codon 
which is in agreement with other functional initiation sequen-
ces [18]. There is 31% overall amino acid identity between 
Supt5hp and its yeast homologue, with the domain 1-816 
displaying a stronger identity of 34%, and the C-terminal 
271 residues showing a weaker one of 25%> (Fig. 3). Supt5hp, 
similar to its yeast counterpart, has a very acidic N-terminal 
domain of 118 amino acid residues 62 of which are either Asp 
or Glu (Fig. 4). Residues 77-81 contain an incomplete (L-D-
E-A-D) DEAD-box motive (normally implicated in ATP 
binding) which, however, lacks the characteristic additional 
conserved domains normally flanking such a motif. A putative 
nuclear localization signal KRKKFKR (residues 328-334), 
may be responsible for the observed nuclear localization of 
Supt5hp. A C-terminal domain of 280 residues, rich in Ser, 
1 MSDSEDSNFS EEEDSERSS 19 
III I I I :h h : 
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245 AQRLAKELRERYGRSSSKCjYRAAAQDGY VPQRFLLPSVDTATIWGVR 291 
184 CKIGEERATAISLKRKFIAYQ--FTDTPLQIKSWAPEHVKGYIYVEAYK 231 
292 CRPGKEKELIRKLLKKKFNLDRAMGKKKLKILsiFQRBNYTGRIYiEAPK 341 
232 OTHVKQAIEGVGNLRLGYWNQQMVPIKEMTDVLKWK--EVANLKPKSIW 279 
342 QSviEKFCNGVPDiYis--QKLLipVQELPLLLKPNKSDDVA'LEEGSYV 388 
280 RLKRGIYKDDIAQVDYVEPSQNTISLKMIPRIDYDR1XA-RMSLKDWFAK 328 
389 RIKRGIYKGDLAMVDQISENNLEVMLKIVPRLDYGKFDEIDPTTQQRKSR 438 
329 RKKF-KRPPQRLFDAEKIRSLGGD—VASDGDFLIFEGNRYSRKGFLFKS 375 
439 RPTFAHRÀPPQLFNPTMALRLDQANLYKRDDRHFTYKNEDYI-DGYLYKS 487 
376 FAMSAVITEGVKPTLSELEKFEDQPEGIDLEWTESTGKEREHN--FOPG 423 
488 FRiQHVETKNiQPTVEELARFGSKEGÀVDLTSVSQSIKKAQAAKVTFQPG 537 
424 DNVEVCEGELINEQGKILSVDGNKITIMPKHEDLKDMLEFPAQELRKYFK 473 
538 DRIEVLBGEQRGSKGIOTRTTKDIATI--KLNGFTTPLEFPISTLRKIFE 585 
474 MGDHVKVIAGRFEGDTGLIVRVEENFVILFSDLTMHELKVLPRDLQLCSE 523 
586 PGDHVTVINGEHQGDAGLVLMVEQGQVTFMSTQTSREVTITANNLSKSID 635 
524 TASGVWGGQHEWGELVQLDPQTVGVIOTLERETFQVLNMYGKWTVRHQ 573 
636 TTAT SSEYALHDivELSAKNVACliQAGHDIFKviDETGKVSTITKG 682 
574 AVTRKKDNRFA'-VALDSEQNNIHVKDIVKVIDGPHSGREGEIRHLFRSF 621 
CTR1 CTR2 
683 SILSKINT. I :VSSVDANGNEIKIGD--TIVEKVGSRREGQVLYIQTQQ 730 G I 
622 AFLHCKKLVENGGMFVCKTRHLVLAGGSKPRDVTNFTVGGFAPMSPRISS 671 
731 IFWSKKivENAGVPVVNPSN-VEAVASKDNMLSN--KMDLSKMNPEIIS 777 
672 PMHPSAGGQRGGFGSPGGGSGGMSRGRGRRTJNELIGQTVRISQGPYKGYI 721 
I I ■ I I : I h I M ' : I I I : 
778 KMGPPSS KTFQQP IQSRGGREVAL-GKTVR1RSAGYKGQL 816 
722 GWKDATESTARVELHSTCQ'TISVDRQRLTTVGSRR?GGM7STYGRTPMY 771 
817 GivKDVHGDKATVELHSKNKHITIDKHKLTYYN--REGGEGITYD 859 
Fig. 3. Sequence homology of Supt5hp (this work, upper lines) and 
yeast Spt5p ([22], lower lines). The C-terminal regions of both se-
quences, with a less significant homology, are omitted. Identities are 
marked '1', related residues are labeled ':' and deletions introduced 
to maximize the homology are indicated by '-'. 
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Fig. 4. Structure of the C-terminal repeats. The C-terminal repeat 
domains (CTR) 1 and 2 are listed and the consensus motifs are giv-
en. On the left side the number of the first residue of each repeat is 
displayed. Below these repeats the consensus sequence of the CTR 
of RNA-polymerase II is listed, which shows a similar pattern. 
Pro and Tyr, contains two different C-terminal repeat motifs 
(Fig. 4), unrelated to the motif S-T/A-W-G-G-A/Q, present in 
yeast Spt5p. The first motif (CTR1) with the consensus se-
quence G-S-R/Q-T-P-X-Y is repeated 9 times and the second, 
less conserved motif (CTR2), with the consensus sequence P-
T/S-P-S-P-Q/A-S/G-Y is repeated 10 times. 
3.4. Cell cycle-dependent phosphorylation of the Supt5hp 
To monitor the amount of Supt5hp throughout the cell 
cycle, we performed immunostaining with AS40 of lysates 
from synchronized HeLa cells. We found the amount to re-
main constant during the cell cycle, like that of actin, while 
the cyclin B level showed its characteristic fluctuation (Fig. 
5A). During mitosis, Supt5hp appeared as a more slowly mi-
grating form in SDS-polyacrylamide gels than in interphase. 
This effect is likely to result from protein phosphorylation, 
since it can be reverted upon treatment with calf intestinal 
phosphatase (Fig. 5B). 
4. Discussion 
Genetic evidence in the yeast S. cerevisiae suggests that 
Spt4p, Spt5p and Spt6p modify chromatin structure and 
thereby change transcriptional regulation of a large number 
of genes in vivo. We have purified Supt5hp, a human homo-
logue of Spt5p and cloned its cDNA. The open reading frame 
of SUPT5H predicts a protein of 1087 amino acid residues, a 
calculated molecular mass of 121 kDa and a pi of 4.8, com-
pared to the yeast Spt5p protein with 1063 residues, a calcu-
lated mass of 116 kDa and a p / of 5.0. Both proteins share 
31% sequence identity. The apparent mass of the purified 
protein as determined by SDS-PAGE is somewhat higher 
than the calculated mass. This discrepancy is probably due 
to the abundance of acidic residues present in Supt5hp, caus-
ing a reduced electrophoretic mobility in SDS-PAGE. Similar 
differences between masses calculated from electrophoretic 
mobilities and from the derived sequence have been described 
for many other proteins [19-21]. 
A carboxyterminal domain of Supt5hp is rich in Ser, Pro 
and Tyr and contains two C-terminal repeat motifs (CTR). 
Nine variants of the consensus sequence G-S-R/Q-T-P-X-Y 
(CTR1) are found and 10 copies of the type P-T/S-P-S-P-Q/ 
A-S/G-Y (CTR2). The yeast Spt5p also contains a C-terminal 
repeat, yet with a different consensus motif (S-T/A-W-G-G-A/ 
Q). The importance of the repeat domain for the yeast protein 
78 A.A. Stachora et al.lFEBS Letters 409 (1997) 74-78 
Supt5hp binds A T P in photolabelling experiments (data not 
shown). This finding is particularly interesting, as proteins 
with a function implicated in the modulat ion of chromatin 
structure were shown to possess an ATPase activity [27,28]. 
We do not know yet whether the incomplete DEAD-box mo-
tif present in Supt5h protein is involved in ATP-binding by 
Supt5hp. 
As yeast Spt4p and human Supt4hp are functional homo-
logues [11], one may expect a similar functional conservation 
from yeast to human for Spt5p and Spt6p and their human 
homologues. Fur ther functional studies will address this issue. 
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